SupplySide West 2019 preview: Arjuna to launch ingredient with potential analgesic effects

October 11, 2019

Arjuna Natural Pvt. Ltd. announced the results of a new study – currently under peer-review – that demonstrates the analgesic activity of its proprietary blend of three botanicals called Rhuleave-K. 

Arjuna Natural Pvt. Ltd. (Kerala, India) announced the results of a new study – currently under peer-review – that demonstrates the analgesic activity of its proprietary blend of three botanicals called Rhuleave-K. The announcement comes in advance of the ingredient’s launch at SupplySide West 2019 in Las Vega, NV.

The study found that Rhuleave-K was equally as effective as the standard over-the-counter (OTC) acetaminophen (Tylenol) in reducing pain intensity and providing pain relief for acute musculoskeletal pain within two hours of consumption. This is significant because prolonged use of OTC analgesics like acetaminophen and ibuprofen may induce liver and renal toxicity, as well as gastrointestinal damage.

“We know it is becoming more critical to develop all-natural pain relief formulas,” said Nipen Lavingia, brand innovation advisor for Arjuna Natural based in Dallas, TX, in a press release. “This study is especially significant since there are few natural products available for immediate pain relief that have similar benefits as OTC analgesics.”